adplus-dvertising
Connect with us

Investment

Cannabis Investment Opportunities Beyond North America’s Borders

Published

 on

Stockhouse cannabis sector investors have watched Canada’s domestic companies take a sometimes rickety rollercoaster ride over the past 12 to 18 months. But the nausea that cannabis can often effectively treat patients can’t necessarily help with the motion sickness investors have felt watching their stocks tumble in the face of a myriad problems licensed producers, cultivators and retailers have faced, and created, over that time.

As a result, savvy investors in the cannabis space are beginning to look outside the box, errr borders, for bona fide opportunities in places some may consider off the beaten path. Like…Latin America.

Did you know that Canada was not the first country to legalize recreational, adult-use cannabis at the federal level? In fact, the South American country of Uruguay passed legislation to legalize recreational cannabis in December 2013, making it the first country in the modern era to legalize cannabis (almost 5 years prior to Canada). Fast- forward to today and you’ll find that Colombia has positioned itself as the newest major player on the Latin American cannabis landscape.

According to Prohibition Partners, Latin America is among the world’s fastest-growing cannabis markets with expected cannabis spending of USD$12-billion by 2028, and an estimated 68 million potential medicinal cannabis patients.

Colombia started along a path toward legalization in 1986, and now has one of the most sophisticated regulatory systems in the continent. The country boasts an ideal climate for cultivation of the plant, tolerant legislation, and low production costs that have recently turned the South American nation into a major hub for international cannabis investments. Today, the local industry is dominated by a few players that have attracted investor attention above others.

One such player is Blueberries Medical Corp. (BBM) (CSE: BBM, OTC: BBRRF, FRA: 1OA, Forum) – a Latin American licensed producer of medicinal cannabis and cannabis-derived products, operating mainly out of the Bogotá Savannah of central Colombia.

Commencing trading on the Canadian Securities Exchange in February 2019, BBM has quickly gained the attention of both public retail and private institutional investment communities in South and North America, as reported in a Stockhouse Top Value Stock Editorial in June.

This innovative Colombian-based company has distinction of being the first Company to have designed and engineered a machine with new stainless-steel extraction vessels that is fully compliant under European Union’s Good Manufacturing Practices (EU-GMP). They also boast 142 exclusive Colombian cannabis strains with high CBD and THC contents with all of the applicable licenses granted by the Colombian Ministries of Justice and Health.

Blueberries Medical Corp. has made a number of strategic moves over the past 18 months to help grow its business and brand globally. Stockhouse investors who’ve traditionally kept a keen eye to North American-only cannabis companies, may want to take a long, hard look at this value opportunity stock.

FULL DISCLOSURE: Blueberries Medical Corp. is a paid client of Stockhouse Publishing.

New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.

Source:- Stockhouse

Source link

Continue Reading

Investment

Tesla shares soar more than 14% as Trump win is seen boosting Elon Musk’s electric vehicle company

Published

 on

 

NEW YORK (AP) — Shares of Tesla soared Wednesday as investors bet that the electric vehicle maker and its CEO Elon Musk will benefit from Donald Trump’s return to the White House.

Tesla stands to make significant gains under a Trump administration with the threat of diminished subsidies for alternative energy and electric vehicles doing the most harm to smaller competitors. Trump’s plans for extensive tariffs on Chinese imports make it less likely that Chinese EVs will be sold in bulk in the U.S. anytime soon.

“Tesla has the scale and scope that is unmatched,” said Wedbush analyst Dan Ives, in a note to investors. “This dynamic could give Musk and Tesla a clear competitive advantage in a non-EV subsidy environment, coupled by likely higher China tariffs that would continue to push away cheaper Chinese EV players.”

Tesla shares jumped 14.8% Wednesday while shares of rival electric vehicle makers tumbled. Nio, based in Shanghai, fell 5.3%. Shares of electric truck maker Rivian dropped 8.3% and Lucid Group fell 5.3%.

Tesla dominates sales of electric vehicles in the U.S, with 48.9% in market share through the middle of 2024, according to the U.S. Energy Information Administration.

Subsidies for clean energy are part of the Inflation Reduction Act, signed into law by President Joe Biden in 2022. It included tax credits for manufacturing, along with tax credits for consumers of electric vehicles.

Musk was one of Trump’s biggest donors, spending at least $119 million mobilizing Trump’s supporters to back the Republican nominee. He also pledged to give away $1 million a day to voters signing a petition for his political action committee.

In some ways, it has been a rocky year for Tesla, with sales and profit declining through the first half of the year. Profit did rise 17.3% in the third quarter.

The U.S. opened an investigation into the company’s “Full Self-Driving” system after reports of crashes in low-visibility conditions, including one that killed a pedestrian. The investigation covers roughly 2.4 million Teslas from the 2016 through 2024 model years.

And investors sent company shares tumbling last month after Tesla unveiled its long-awaited robotaxi at a Hollywood studio Thursday night, seeing not much progress at Tesla on autonomous vehicles while other companies have been making notable progress.

Tesla began selling the software, which is called “Full Self-Driving,” nine years ago. But there are doubts about its reliability.

The stock is now showing a 16.1% gain for the year after rising the past two days.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Investment

S&P/TSX composite up more than 100 points, U.S. stock markets mixed

Published

 on

 

TORONTO – Canada’s main stock index was up more than 100 points in late-morning trading, helped by strength in base metal and utility stocks, while U.S. stock markets were mixed.

The S&P/TSX composite index was up 103.40 points at 24,542.48.

In New York, the Dow Jones industrial average was up 192.31 points at 42,932.73. The S&P 500 index was up 7.14 points at 5,822.40, while the Nasdaq composite was down 9.03 points at 18,306.56.

The Canadian dollar traded for 72.61 cents US compared with 72.44 cents US on Tuesday.

The November crude oil contract was down 71 cents at US$69.87 per barrel and the November natural gas contract was down eight cents at US$2.42 per mmBTU.

The December gold contract was up US$7.20 at US$2,686.10 an ounce and the December copper contract was up a penny at US$4.35 a pound.

This report by The Canadian Press was first published Oct. 16, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

S&P/TSX up more than 200 points, U.S. markets also higher

Published

 on

 

TORONTO – Canada’s main stock index was up more than 200 points in late-morning trading, while U.S. stock markets were also headed higher.

The S&P/TSX composite index was up 205.86 points at 24,508.12.

In New York, the Dow Jones industrial average was up 336.62 points at 42,790.74. The S&P 500 index was up 34.19 points at 5,814.24, while the Nasdaq composite was up 60.27 points at 18.342.32.

The Canadian dollar traded for 72.61 cents US compared with 72.71 cents US on Thursday.

The November crude oil contract was down 15 cents at US$75.70 per barrel and the November natural gas contract was down two cents at US$2.65 per mmBTU.

The December gold contract was down US$29.60 at US$2,668.90 an ounce and the December copper contract was up four cents at US$4.47 a pound.

This report by The Canadian Press was first published Oct. 11, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending